Related Experiment Video
Updated: Jul 9, 2026

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
Downregulation of myc promoter-binding protein 1 (MBP-1) in growth-arrested malignant B cells
1Institute of Pathology, Charles University in Prague, 1st Faculty of Medicine and General Teaching Hospital, Prague, Czech Republic. Daniel.Tvrdik@vfn.cz
Abstract:
Normal human B lymphocytes are sensitive to the growth-inhibitory action of TGF-beta1 whereas malignant B lymphoma cells are mostly resistant to TGF-beta1 effects. We have shown in our previous work that, TGF-beta1 treatment resulted in significant growth inhibition of the DoHH2 cell line. In the present study we showed that TGF-beta1-induced growth arrest was associated with notable downregulation of the myc-binding protein-1 (MBP-1). Moreover, our results indicated that c-Myc overexpression in TGF-beta1-arrested malignant B cells is mediated by binding of MBP-1, as a transcription repressor, to the (+118/+153) element of the promoter region of the myc gene.
Insights
Transforming growth factor-beta1 (TGF-beta1) inhibits malignant B lymphoma cell growth by downregulating myc-binding protein-1 (MBP-1). This leads to c-Myc overexpression via MBP-1 binding to the myc gene promoter.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Normal B lymphocytes are sensitive to TGF-beta1 growth inhibition, but malignant B lymphoma cells often exhibit resistance.
- Previous studies demonstrated TGF-beta1's significant growth inhibition of the DoHH2 cell line.
Purpose of the Study:
- To investigate the molecular mechanisms underlying TGF-beta1-induced growth arrest in malignant B cells.
- To elucidate the role of myc-binding protein-1 (MBP-1) and c-Myc in TGF-beta1's effects on B lymphoma cells.
Main Methods:
- Treatment of DoHH2 malignant B cells with TGF-beta1.
- Analysis of MBP-1 expression levels following TGF-beta1 treatment.
- Investigation of the binding of MBP-1 to the myc gene promoter region.
Main Results:
- TGF-beta1 treatment led to significant growth arrest in DoHH2 cells.
- TGF-beta1-induced growth arrest was correlated with a notable downregulation of MBP-1.
- c-Myc overexpression in arrested cells was mediated by MBP-1 acting as a transcription repressor, binding to the (+118/+153) element of the myc promoter.
Conclusions:
- MBP-1 downregulation is a key event in TGF-beta1-induced growth arrest of malignant B cells.
- MBP-1 plays a critical role in regulating c-Myc expression in response to TGF-beta1.
- The interaction between MBP-1 and the myc promoter offers a potential therapeutic target for B cell lymphomas.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic cells are...
Negative Regulator Molecules
Master Transcription Regulators
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
